Medicine and Dentistry
Adverse Event
25%
Anemia
50%
Breast Cancer
25%
Clinical Trial
25%
Erythrocyte
25%
Everolimus
100%
Hemoglobin Determination
25%
Immunosuppressive Treatment
25%
Infection
25%
Leukocyte
25%
Leukopenia
50%
Lymphocyte
25%
Lymphocytopenia
25%
Mean Corpuscular Volume
50%
Mechanistic Target of Rapamycin
25%
Metastatic Breast Cancer
100%
Microcytosis
25%
Mixed Model
25%
Neutrophil
25%
Nonoxinol 9
25%
Oncologist
25%
Student T Test
25%
Thrombocytopenia
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
25%
Anemia
50%
Breast Cancer
25%
Clinical Trial
25%
Everolimus
100%
Infection
25%
Leukopenia
50%
Lymphocytopenia
25%
Mammalian Target of Rapamycin
25%
Metastatic Breast Cancer
100%
Microcytosis
25%
Mixed Model
25%
Nonoxynol-9
25%
Thrombocytopenia
50%
Immunology and Microbiology
Blood Cell Count
25%
Erythrocyte
25%
Everolimus
100%
Hemoglobin
25%
Infection
25%
Leukocyte Count
25%
Lymphocyte
25%
Lymphocytopenia
25%
Mean Corpuscular Hemoglobin
75%
Mean Corpuscular Volume
50%
Neutrophil
25%
Nonoxynol-9
25%
Sirolimus
25%